USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12984
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDodul, Cristina
dc.contributor.authorVetrilă, Snejana
dc.date.accessioned2020-11-13T16:58:48Z
dc.date.available2020-11-13T16:58:48Z
dc.date.issued2020-10
dc.identifier.urihttps://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12984
dc.descriptionUniversitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Disciplina de cardiologie, Chișinău, Republica Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltareen_US
dc.description.abstractIntroduction.Aortic stenosis (SA) is the most common valvular heart disease and the third cardiovascular disease after hypertension and coronary heart disease in Western countries. There is currently no definite medical treatment that can delay or stop the progression of the disease. Therefore, risk assessment is needed to develop new strategies to prevent and slow the progression of the disease.Purpose.Evaluation of lipid profile and atherogenic index of plasma in patients with aortic stenosis to optimize treatment.Material and methods.We conducted a transversal, prospective study that included 46 patients with a diagnosis of aortic stenosis confirmed by echocardiography. Patients were examined according to a questionnaire, which included general data and lipid profile parameters. We calculated non-HDL cholesterol and the Atherogenic Index of Plasma (IAP).Results.The mean age of the group was 64.3 ± 0.03 years. Evaluation of risk factors found hypertension in 28 (60.8%) cases, obesity - 33 (71.7%), dyslipidemia-18 (39.1%). Evaluation of the lipidogram showed a high level of total cholesterol in 18 (39.1%) cases, LDL-cholesterol - 13 (28.2%), triglycerides in 9 (19.5%) cases, and a low level of HDL was attested in 14 (30.4%) cases. Ideal values of non-HDL cholesterol (<3.4 mmol / l) were obtained in 17 (36.9%) patients. IAP indicated a moderate risk of developing atherosclerosis in 10 (21.7%) and an increased risk - in 6 (13.0%) cases.Conclusions.Dyslipidemia is common in patients with aortic stenosis, being attested in 39.1% of cases, and the atherogenic index of plasma with an increased risk of developing atherosclerosis in 34.7% of cases. Therefore the control of the lipid profile in aortic stenosis is essential in management of these patients.en_US
dc.language.isoenen_US
dc.publisherUniversitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldovaen_US
dc.subjectaortic stenosisen_US
dc.subjectdyslipidemiaen_US
dc.subjectatherogenic indexen_US
dc.subjectnon-HDL cholesterolen_US
dc.titleDyslipidemia: the risc factor of aortic stenosisen_US
dc.typeOtheren_US
Appears in Collections:Culegere de postere

Files in This Item:
File Description SizeFormat 
Dodul_Cristina.pdf257.78 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback